Publication:
Blocking the CCL2-CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model

cris.lastimport.scopus2025-04-27T21:22:35Z
cris.virtual.departmentAnatomy and Cell Biologyen_US
cris.virtual.orcid0000-0002-9444-4192en_US
cris.virtualsource.department3d1440ca-9f18-4bfc-a7df-bae2af535ee2
cris.virtualsource.orcid3d1440ca-9f18-4bfc-a7df-bae2af535ee2
dc.contributor.authorTeng K.-Y.en_US
dc.contributor.authorHan J.en_US
dc.contributor.authorZhang X.en_US
dc.contributor.authorSHU-HAO HSUen_US
dc.contributor.authorHe S.en_US
dc.contributor.authorWani N.A.en_US
dc.contributor.authorBarajas J.M.en_US
dc.contributor.authorSnyder L.A.en_US
dc.contributor.authorFrankel W.L.en_US
dc.contributor.authorCaligiuri M.A.en_US
dc.contributor.authorJacob S.T.en_US
dc.contributor.authorYu J.en_US
dc.contributor.authorGhoshal K.en_US
dc.creatorTeng K.-Y.;Han J.;Zhang X.;Shu-Hao Hsu;He S.;Wani N.A.;Barajas J.M.;Snyder L.A.;Frankel W.L.;Caligiuri M.A.;Jacob S.T.;Yu J.;Ghoshal K.
dc.date.accessioned2020-03-02T07:14:41Z
dc.date.available2020-03-02T07:14:41Z
dc.date.issued2017
dc.identifier.doi10.1158/1535-7163.MCT-16-0124
dc.identifier.issn1535-7163
dc.identifier.pmid27980102
dc.identifier.scopus2-s2.0-85011655226
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85011655226&doi=10.1158%2f1535-7163.MCT-16-0124&partnerID=40&md5=4aaa019e0f7637be05d38347a9b04a6a
dc.identifier.urihttps://scholars.lib.ntu.edu.tw/handle/123456789/467348
dc.publisherAmerican Association for Cancer Research Inc.
dc.relation.ispartofMolecular Cancer Therapeutics
dc.relation.journalissue2
dc.relation.journalvolume16
dc.relation.pages312-322
dc.subject.classification[SDGs]SDG3
dc.titleBlocking the CCL2-CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse modelen_US
dc.typejournal articleen
dspace.entity.typePublication

Files